1. Home
  2. SGHT vs WIA Comparison

SGHT vs WIA Comparison

Compare SGHT & WIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$8.62

Market Cap

193.2M

Sector

Health Care

ML Signal

HOLD

Logo Western Asset Inflation-Linked Income Fund

WIA

Western Asset Inflation-Linked Income Fund

HOLD

Current Price

$8.26

Market Cap

197.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
WIA
Founded
2011
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
193.2M
197.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SGHT
WIA
Price
$8.62
$8.26
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$6.66
N/A
AVG Volume (30 Days)
186.6K
39.2K
Earning Date
11-06-2025
01-01-0001
Dividend Yield
N/A
12.29%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$76,052,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$7.56
52 Week High
$8.80
$8.91

Technical Indicators

Market Signals
Indicator
SGHT
WIA
Relative Strength Index (RSI) 65.41 39.17
Support Level $8.04 $8.19
Resistance Level $8.63 $8.29
Average True Range (ATR) 0.51 0.06
MACD -0.09 -0.00
Stochastic Oscillator 88.12 25.00

Price Performance

Historical Comparison
SGHT
WIA

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About WIA Western Asset Inflation-Linked Income Fund

Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.

Share on Social Networks: